Meyer Handelman Co Lifted By $740,286 Its General Electric Com (GE) Position; Ampio Pharmaceuticals (AMPE) Has 0.55 Sentiment

December 12, 2017 - By Darrin Black

Ampio Pharmaceuticals, Inc., a development stage biopharmaceutical company, focuses on the development of therapies for the treatment of prevalent inflammatory conditions in the United States. The company has market cap of $127.58 million. The firm is developing compounds that decrease inflammation by inhibiting specific pro-inflammatory compounds by affecting specific pathways at the protein expression and at the transcription level; activating specific phosphatase or depleting available phosphate needed for the inflammation process; and decreasing vascular permeability. It currently has negative earnings. The Company’s product pipeline includes Ampion, an intra-articular injection for the treatment of osteoarthritis of the knee; and Optina, which has completed Phase II clinical trials for diabetic macular edema.

Meyer Handelman Co increased General Electric Corp Com (GE) stake by 1.08% reported in 2017Q2 SEC filing. Meyer Handelman Co acquired 27,418 shares as General Electric Corp Com (GE)’s stock declined 7.64%. The Meyer Handelman Co holds 2.57 million shares with $69.41 million value, up from 2.54M last quarter. General Electric Corp Com now has $155.32B valuation. The stock increased 1.47% or $0.26 during the last trading session, reaching $17.91. About 66.41 million shares traded. General Electric Company (NYSE:GE) has declined 4.46% since December 12, 2016 and is downtrending. It has underperformed by 21.16% the S&P500.

Among 25 analysts covering General Electric Company (NYSE:GE), 10 have Buy rating, 5 Sell and 10 Hold. Therefore 40% are positive. General Electric Company had 79 analyst reports since July 21, 2015 according to SRatingsIntel. The stock of General Electric Company (NYSE:GE) earned “Market Perform” rating by Bernstein on Monday, April 4. RBC Capital Markets maintained General Electric Company (NYSE:GE) rating on Friday, September 15. RBC Capital Markets has “Buy” rating and $31.0 target. The stock of General Electric Company (NYSE:GE) earned “Buy” rating by Stifel Nicolaus on Friday, July 7. The firm has “Hold” rating given on Monday, June 12 by Cowen & Co. William Blair upgraded the stock to “Outperform” rating in Tuesday, October 13 report. The stock has “Hold” rating by Oppenheimer on Monday, July 24. The firm earned “Underweight” rating on Monday, October 23 by Morgan Stanley. The stock of General Electric Company (NYSE:GE) has “Sector Perform” rating given on Tuesday, November 14 by RBC Capital Markets. The stock of General Electric Company (NYSE:GE) has “Equal-Weight” rating given on Tuesday, July 25 by Morgan Stanley. The firm has “Buy” rating by Bank of America given on Tuesday, November 14.

Investors sentiment decreased to 0.69 in 2017 Q2. Its down 0.10, from 0.79 in 2017Q1. It dropped, as 85 investors sold GE shares while 816 reduced holdings. 111 funds opened positions while 598 raised stakes. 4.61 billion shares or 0.66% more from 4.58 billion shares in 2017Q1 were reported. Aull & Monroe Inv Mngmt Corp has 1.77% invested in General Electric Company (NYSE:GE) for 122,863 shares. Utd Automobile Association has 0.53% invested in General Electric Company (NYSE:GE). North Amer Management Corporation has 3.94% invested in General Electric Company (NYSE:GE). 10,176 were accumulated by Dsc Advsrs Limited Partnership. Paradigm Fincl Limited Company holds 2.75% or 200,970 shares. Murphy Capital Mgmt has invested 0.89% in General Electric Company (NYSE:GE). Washington Tru Bancorporation reported 1.19% of its portfolio in General Electric Company (NYSE:GE). Tirschwell And Loewy holds 1.19% or 281,511 shares in its portfolio. 225,928 are owned by Iberiabank Corp. Invest Counselors Of Maryland Llc, a Maryland-based fund reported 37,309 shares. Hbk Limited Partnership invested 0.13% in General Electric Company (NYSE:GE). Culbertson A N & Communication, Virginia-based fund reported 167,425 shares. Pinnacle Wealth Advisory Grp Ltd owns 0.45% invested in General Electric Company (NYSE:GE) for 27,132 shares. Schwab Charles Mngmt owns 29.01M shares or 0.74% of their US portfolio. Ntv Asset Mngmt Ltd Liability Company has invested 1.72% of its portfolio in General Electric Company (NYSE:GE).

Meyer Handelman Co decreased Ppg Inds Inc (NYSE:PPG) stake by 7,000 shares to 253,052 valued at $27.83M in 2017Q2. It also reduced Dow Chem Company Com (NYSE:DOW) stake by 6,400 shares and now owns 447,122 shares. Philip Morris Intl Inc (NYSE:PM) was reduced too.

Knoll Capital Management Lp holds 1.79% of its portfolio in Ampio Pharmaceuticals, Inc. for 2.60 million shares. Noven Financial Group Inc. owns 245,667 shares or 0.08% of their US portfolio. Moreover, Element Capital Management Llc has 0.03% invested in the company for 290,312 shares. The Colorado-based Ghp Investment Advisors Inc. has invested 0.01% in the stock. Lmr Partners Llp, a United Kingdom-based fund reported 157,455 shares.

The stock increased 4.35% or $0.07 during the last trading session, reaching $1.68. About 609,961 shares traded. Ampio Pharmaceuticals, Inc. (AMPE) has declined 79.44% since December 12, 2016 and is downtrending. It has underperformed by 96.14% the S&P500.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Twitter Auto Publish Powered By : XYZScripts.com